Perspective Therapeutics (CATX)
Develops image-guided lead-212 cancer therapies with paired lead-203 imaging.
$3.01
After hours+0.05 (+1.76%)
At close$2.96(−0.51%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Insiders | 6.20% | 7.07M shares | |
|---|---|---|---|
| 1 holder · as of Feb 5, 2026 | |||
| Strategic holders | 27.53% | 31.43M shares | |
| 4 holders · as of Sep 3, 2026 | |||
| Other | 66.27% | 75.65M shares | |
| remainder | |||
114.15M company shares as of Sep 22, 2026 · holders as of their latest filing
13F
No 13F holders on record.
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Lantheus Holdings, Inc.incl. Lantheus Alpha Therapy, LLC, Lantheus Medical Imaging, Inc. | 10.00% | 11.44M | 13D | Sep 4, 2026 |
| Commodore Capital LP | 9.90% | 11.94M | 13G | Feb 9, 2026 |
| FMR LLCincl. Abigail P. Johnson | 8.16% | 5.50M | Nov 7, 2024 | |
| Ein #incl. Janus Henderson Group plc | 7.10% | 4.80M | Nov 14, 2024 | |
| BlackRock, Inc. | 6.80% | 7.78M | 13G | Jul 29, 2026 |
| Qatar Investment Authority | 6.20% | 7.07M | 13G | Feb 5, 2026 |
| State Street Corporation | 5.30% | 6.05M | 13G | Aug 7, 2026 |
| Millennium Management LLC | 5.30% | 6.04M | 13G | Jul 20, 2026 |
| Avidity Partners Management LP | 5.30% | 6.05M | 13G | Mar 10, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC10 percent owner | Sale | 167,149 | $3.15 | 11,273,364 |
| Sep 3, 2026 | Lantheus Alpha Therapy, LLC10 percent owner | Sale | 80,783 | $3.11 | 11,440,513 |
| Sep 2, 2026 | Lantheus Alpha Therapy, LLC10 percent owner | Sale | 42,129 | $3.11 | 11,521,296 |
| Sep 1, 2026 | Lantheus Alpha Therapy, LLC10 percent owner | Sale | 35,769 | $3.12 | 11,563,425 |
| Aug 31, 2026 | Lantheus Alpha Therapy, LLC10 percent owner | Sale | 78,145 | $3.14 | 11,599,194 |
| Sep 1, 2026 | Lantheus Holdings, Inc.10 percent owner | Sale | 35,769 | $3.12 | 11,563,425 |
| Aug 31, 2026 | Lantheus Holdings, Inc.10 percent owner | Sale | 78,145 | $3.14 | 11,599,194 |
House and Senate disclosures
Not reported.